Literature DB >> 19653340

Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.

Mohammed Abdelhamid El-Bokl1, Bahaa Eldeen Senousy, Khaled Zakaria El-Karmouty, Inas El Khedr Mohammed, Sherif Monier Mohammed, Sherif Sadek Shabana, Hassan Shalaby.   

Abstract

AIM: To evaluate the accuracy of spot urinary Na/K and Na/creatinine (Cr) ratios as an alternative to 24-h urinary sodium in monitoring dietary compliance in patients with liver cirrhosis and ascites treated with diuretics.
METHODS: The study was carried on 40 patients with liver cirrhosis and ascites treated with diuretic therapy. Patients were divided into two groups according to 24-h urinary sodium. We measured spot urine Na/K ratio, Na/Cr ratio and 24-h urinary sodium. Student's t test was used to compare the interval variables and chi(2) test to compare the nominal variables between the two groups. Receiver operator characteristic curve was used to identify the best cutoff point for Na/K and Na/Cr ratio.
RESULTS: The best cutoff point for Na/K ratio was 2.5 (P < 0.001) and area under the curve (AUC) was 0.9, and for Na/Cr ratio, the best cutoff point was 35 (P < 0.001) and AUC was 0.885. Na/K ratio showed higher sensitivity and accuracy compared to Na/Cr ratio (87.5% and 87% for Na/K ratio; 81% and 85% for Na/Cr ratio, respectively).
CONCLUSION: Spot urine Na/K ratio has adequate accuracy for assessment of dietary sodium restriction compared with 24-h urinary sodium in patients with liver cirrhosis and ascites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653340      PMCID: PMC2721236          DOI: 10.3748/wjg.15.3631

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Mechanisms of ascites formation.

Authors:  A Cárdenas; R Bataller; V Arroyo
Journal:  Clin Liver Dis       Date:  2000-05       Impact factor: 6.126

2.  Management of adult patients with ascites due to cirrhosis.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

3.  The correlation between cytopenia and esophageal varices in patients with liver cirrhosis.

Authors:  C S Gue; C K Yap; H S Ng
Journal:  Med J Malaysia       Date:  2004-12

4.  Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study.

Authors:  Edoardo G Giannini; Atif Zaman; Anna Kreil; Annarosa Floreani; Pietro Dulbecco; Emanuela Testa; Roya Sohaey; Peter Verhey; Markus Peck-Radosavljevic; Carlo Mansi; Vincenzo Savarino; Roberto Testa
Journal:  Am J Gastroenterol       Date:  2006-10-04       Impact factor: 10.864

Review 5.  Hyponatremia in cirrhosis: from pathogenesis to treatment.

Authors:  P Ginés; T Berl; M Bernardi; D G Bichet; G Hamon; W Jiménez; J F Liard; P Y Martin; R W Schrier
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

Review 6.  Management of ascites.

Authors:  A S Yu; K Q Hu
Journal:  Clin Liver Dis       Date:  2001-05       Impact factor: 6.126

7.  Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.

Authors:  L Spahr; J P Villeneuve; H K Tran; G Pomier-Layrargues
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

Review 8.  The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.

Authors:  Kevin P Moore; Florence Wong; Pere Gines; Mauro Bernardi; Andreas Ochs; Francesco Salerno; Paolo Angeli; Michael Porayko; Richard Moreau; Guadelupe Garcia-Tsao; Wladimiro Jimenez; Ramon Planas; Vicente Arroyo
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

Review 9.  The management of ascites and hyponatremia in cirrhosis.

Authors:  Pere Ginès; Andrés Cárdenas
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115

10.  [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].

Authors:  Hyun Seok Cho; Geun Tae Park; Young Hoon Kim; Sung Gon Shim; Jin Bae Kim; Oh Young Lee; Ho Soon Choi; Joon Soo Hahm; Min Ho Lee
Journal:  Taehan Kan Hakhoe Chi       Date:  2003-12
View more
  7 in total

Review 1.  INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.

Authors:  Anil Arora; Ashish Kumar; Narayan Prasad; Ajay Duseja; Subrat K Acharya; Sanjay K Agarwal; Rakesh Aggarwal; Anil C Anand; Anil K Bhalla; Narendra S Choudhary; Yogesh K Chawla; Radha K Dhiman; Vinod K Dixit; Natarajan Gopalakrishnan; Ashwani Gupta; Umapati N Hegde; Sanjiv Jasuja; Vivek Jha; Vijay Kher; Ajay Kumar; Kaushal Madan; Rakhi Maiwall; Rajendra P Mathur; Suman L Nayak; Gaurav Pandey; Rajendra Pandey; Pankaj Puri; Ramesh R Rai; Sree B Raju; Devinder S Rana; Padaki N Rao; Manish Rathi; Vivek A Saraswat; Sanjiv Saxena; Praveen Sharma; Shivaram P Singh; Ashwani K Singal; Arvinder S Soin; Sunil Taneja; Santosh Varughese
Journal:  J Clin Exp Hepatol       Date:  2020-10-09

2.  Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.

Authors:  Takuya Iwamoto; Masaki Maeda; Takuro Hisanaga; Issei Saeki; Koichi Fujisawa; Toshihiko Matsumoto; Isao Hidaka; Tsuyoshi Ishikawa; Taro Takami; Isao Sakaida
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

3.  Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.

Authors:  Yasuyuki Komiyama; Masayuki Kurosaki; Hiroyuki Nakanishi; Yuka Takahashi; Jun Itakura; Yutaka Yasui; Nobuharu Tamaki; Hitomi Takada; Mayu Higuchi; Tomoyuki Gotou; Youhei Kubota; Kenta Takaura; Tsuguru Hayashi; Wann Oh; Mao Okada; Nobuyuki Enomoto; Namiki Izumi
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

4.  Guidelines on the management of ascites in cirrhosis.

Authors:  Guruprasad P Aithal; Naaventhan Palaniyappan; Louise China; Suvi Härmälä; Lucia Macken; Jennifer M Ryan; Emilie A Wilkes; Kevin Moore; Joanna A Leithead; Peter C Hayes; Alastair J O'Brien; Sumita Verma
Journal:  Gut       Date:  2020-10-16       Impact factor: 23.059

5.  Salt intake and the association with blood pressure in young Iranian children: first report from the middle East and north Africa.

Authors:  Roya Kelishadi; Alaleh Gheisari; Narges Zare; Sanam Farajian; Keyvan Shariatinejad
Journal:  Int J Prev Med       Date:  2013-04

6.  Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Authors:  Thomas Reiberger; Andreas Püspök; Maria Schoder; Franziska Baumann-Durchschein; Theresa Bucsics; Christian Datz; Werner Dolak; Arnulf Ferlitsch; Armin Finkenstedt; Ivo Graziadei; Stephanie Hametner; Franz Karnel; Elisabeth Krones; Andreas Maieron; Mattias Mandorfer; Markus Peck-Radosavljevic; Florian Rainer; Philipp Schwabl; Vanessa Stadlbauer; Rudolf Stauber; Herbert Tilg; Michael Trauner; Heinz Zoller; Rainer Schöfl; Peter Fickert
Journal:  Wien Klin Wochenschr       Date:  2017-10-23       Impact factor: 1.704

7.  Development of objective indicators for quantitative analysis of sodium intake: the sodium to potassium ratio of second-void urine is correlated with 24-hour urinary sodium excretion.

Authors:  Jung Gon Kim; Sang-Woong Han; Joo Hark Yi; Hyeong Cheon Park; Sang Youb Han
Journal:  Nutr Res Pract       Date:  2019-11-05       Impact factor: 1.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.